VOR Vor Biopharma Inc

Price (delayed)

$19.37

Market cap

$1.15B

P/E Ratio

0.11

Dividend/share

N/A

EPS

$179.71

Enterprise value

$1.04B

?
Relative Growth: Rel. Growth: 28
Relative Strength: Rel. Strength: 79
Relative Valuation: Rel. Valuation: 93
Relative Profitability: Rel. Profitability: 35
Highlights
The net income has soared by 171% from the previous quarter and by 138% YoY
VOR's EPS has soared by 166% YoY
Vor Biopharma's equity has soared by 87% YoY but it has decreased by 33% from the previous quarter
Vor Biopharma's quick ratio has decreased by 39% from the previous quarter

Key stats

What are the main financial stats of VOR

VOR stock price

How has the Vor Biopharma stock price performed over time
Intraday
-11.95%
1 week
-11.75%
1 month
-17.08%
1 year
-38.08%
YTD
48.09%
QTD
5.21%

Financial performance

How have Vor Biopharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$147.08M
Net income
$627.78M
Gross margin
N/A
Net margin
N/A
The net income has soared by 171% from the previous quarter and by 138% YoY
The company's operating income has surged by 61% QoQ and by 60% YoY

Price vs fundamentals

How does VOR's price correlate with its fundamentals

Growth

What is Vor Biopharma's growth rate over time

Valuation

What is Vor Biopharma stock price valuation
P/E
0.11
P/B
N/A
P/S
N/A
EV/EBIT
1.66
EV/EBITDA
1.66
EV/Sales
N/A
VOR's EPS has soared by 166% YoY
Vor Biopharma's equity has soared by 87% YoY but it has decreased by 33% from the previous quarter

Efficiency

How efficient is Vor Biopharma business performance
The return on assets has surged by 159% since the previous quarter and by 113% year-on-year
The return on invested capital has surged by 132% since the previous quarter and by 109% year-on-year

Dividends

What is VOR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VOR.

Financial health

How did Vor Biopharma financials performed over time
Vor Biopharma's total assets is 29% less than its total liabilities
Vor Biopharma's total assets has soared by 134% YoY but it has decreased by 5% from the previous quarter
VOR's total liabilities has shrunk by 60% YoY but it is up by 3.7% QoQ
The debt is 101% more than the equity
Vor Biopharma's equity has soared by 87% YoY but it has decreased by 33% from the previous quarter
Vor Biopharma's debt to equity has surged by 50% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.